{"id":245973,"date":"2026-10-26T17:05:34","date_gmt":"2026-10-26T22:05:34","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/10\/incyte-pancreatic-cancer-medicine-induces-lasting-tumor-responses-company-says-at-esmo"},"modified":"2026-10-26T17:05:34","modified_gmt":"2026-10-26T22:05:34","slug":"incyte-pancreatic-cancer-medicine-induces-lasting-tumor-responses-company-says-at-esmo","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/10\/incyte-pancreatic-cancer-medicine-induces-lasting-tumor-responses-company-says-at-esmo","title":{"rendered":"Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO"},"content":{"rendered":"\n<p>MADRID \u2014 A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer \u2014 results, the biotech said, that support its prior decision to advance the treatment into a late-stage clinical trial.<\/p>\n<p>The <a href=\"https:\/\/www.statnews.com\/2026\/09\/08\/pancreatic-cancer-patients-caught-beween-fda-drug-approval-insurance-coverage\/\" type=\"post\" id=\"1517396\">approval of Revolution Medicines\u2019 pancreatic cancer drug Rasonque<\/a> earlier this year showed that a medicine capable of attacking mutations in a group of genes called RAS could prolong survival for patients with the particularly aggressive cancer.<\/p>\n<p>Now, companies like Incyte, Revolution Medicines, Verastem, and China\u2019s Hengrui are developing next-generation drugs that selectively target specific mutations within the RAS family of genes, seeking even better results for patients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MADRID \u2014 A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer \u2014 results, the biotech said, that support its prior decision to advance the treatment into a late-stage clinical trial. The approval of Revolution Medicines\u2019 pancreatic cancer drug Rasonque earlier this year showed [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-245973","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/245973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=245973"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/245973\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=245973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=245973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=245973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}